Skip to main content
PLOS One logoLink to PLOS One
. 2021 Feb 17;16(2):e0247105. doi: 10.1371/journal.pone.0247105

Risk factors associated with cardiovascular disease among adult Nevadans

Dieu-My T Tran 1,*,#, Nirmala Lekhak 1,#, Karen Gutierrez 2, Sheniz Moonie 2,#
Editor: Sabine Rohrmann3
PMCID: PMC7888645  PMID: 33596242

Abstract

Objective

Cardiovascular disease (CVD) remains the number one cause of death in the US and Nevada is ranked 11th highest for CVD mortality. The study sought to examine the association between self-reported risk factors and CVD presence among adult Nevadans, between years 2011 and 2017.

Methods

This is a cross-sectional, population-based study that utilized the 2011 and 2017 Nevada Behavioral Risk Factor Surveillance System data. Data were analyzed between 2019 and 2020.

Results

A total of 5,493 and 3,764 subjects in 2011 and 2017, respectively were included. BMI (overweight/obesity) remained the most prevalent CVD risk factor. The second most common CVD risk factor was high cholesterol, followed by hypertension. Compared to females, males were 1.64 times more likely to have reported CVD in 2011, which increased to 1.92 in 2017. Compared to non-smokers, everyday smokers were 1.96 times more likely in 2011 and 3.62 times more likely in 2017. Individuals with high cholesterol status were 2.67 times more likely to have reported CVD compared to those with normal levels in 2011. In 2011, individuals with hypertension were 3.74 times more likely to have reported CVD compared to those who did not have hypertension. This relationship increased its magnitude of risk to 6.18 times more likely in 2017. In 2011, individuals with diabetes were 2.90 times more likely to have reported CVD compared to those without the condition.

Conclusions

Public health and healthcare providers need to target preventable cardiovascular risk factors and develop recommendations and strategies locally, nationally, and globally.

Introduction

Cardiovascular disease (CVD) remains the number one cause of death in the United States and globally. CVD accounts for 17.6 million deaths globally, which is an increase of 14.5% from 2006. During 2014 in the U.S., CVD and stroke accounted for an estimated 325.2 billion in direct and indirect costs, and this estimate is projected to increase [1]. Specifically, the prevalence of CVD in adults ages 20 years and older is 48% with increasing risk with advancing age in both males and females [1].

Multiple CVD risk factors such as smoking and high blood pressure place individuals at increased risk for CVD events. These risk factors tend to co-occur, thus further amplifying the risk [2]. Approximately half of American adults have at least one of three key cardiovascular risk factors (hypertension, hyperlipidemia, and smoking) despite the majority of these risk factors being preventable [3]. Hypertension is a significant risk factor for CVD, and it is the most prevalent risk factor. From 2011 to 2014, the prevalence of hypertension was 45.6% in adults using the new blood pressure classification (systolic blood pressure ≥ 130 mm Hg or diastolic blood pressure ≥ 80 mm Hg [4]. In contrast, it was 31.9% using the old guidelines (systolic blood pressure ≥ 140 mm Hg or diastolic blood pressure ≥ 80 mm Hg [5]. One of the strongest predictors of hypertension is the high intake of sodium [6]. According to a 2013, nationally representative sample of 827 adults, sodium intake was 4205 mg/d for males and 3039 mg/d for females, exceeding the recommendation of 2300 mg/d [1]. According to the American Heart Association (AHA) most recent guideline updates, among the cardiovascular risk factors, tobacco use remains a leading cause of preventable death in the United States and across the globe [1]. Tobacco use damages the heart and blood vessels, and nicotine raises blood pressure [3]. From 2013 to 2016, 26 million adults were diagnosed with diabetes mellitus, excluding the 9.4 million adults being undiagnosed. Adults who have diabetes have a higher risk of death from CVD compared to adults who do not have diabetes [3].

Additionally, a higher body mass index (BMI) was and continues to be associated with a significantly higher risk of CVD death. The prevalence of obesity was 39.6% among American adults [1]. However, literature supporting that a sedentary lifestyle is associated with an increased risk of cardiovascular events and mortality, less than 23% of adults report participating in inadequate amounts of physical activity meeting the 2008 federal guidelines [1]. One of the leading causes of the increase in sedentary activity is the increase in technology usage, especially smartphones.

Comparatively, Nevada is ranked 11th highest for CVD death rate in the U.S [1, 7]. In 2010, Nevadan adults who suffered from a heart attack were higher compared to the national average (5.0% versus 4.2%, respectively) [8]. Based on the 2017 data, 6,417 people died of CVD in Nevada [7]. When comparing Nevada CVD and stroke risk factors to the United States, Nevada reported a slightly higher prevalence of current smokers (17.6% versus 17.1%, respectively) as well as fewer individuals participating in more than 150 minutes of aerobic physical activity per week (65.7% versus 66.6%, respectively) [7]. However, Nevada has a lower prevalence of being overweight or obese (based on self-reported BMI) compared to the nation (65.7% versus 66.6%, respectively) [7]. It is of interest to explore the cardiovascular risk factors present among adult Nevadans and identify changes over the last decade to encourage proper funding and prevention/intervention of CVD. The purpose of this study was to examine the association between self-reported risk factors (heavy drinking, smoking, high cholesterol, hypertension, overweight/obesity, and diabetes) and CVD presence among adult Nevadans. A comparison of these factors between years 2011 and 2017 was assessed.

Materials and methods

This is a cross-sectional, population-based study that utilizes the 2011 and 2017 Nevada Behavioral Risk Factor Surveillance System (BRFSS) data [9]. The BRFSS is an annual random digit dial (RDD) telephone survey that collaborates with the Centers for Disease Control and Prevention and each state across the Nation and U.S territories. Self-reported health conditions and risk behaviors are gathered across a representative sample of non-institutionalized adults 18 years and older for surveillance purposes. In an attempt to capture all segments of the population, landlines and cellular phones are incorporated. State health departments conduct telephone surveys, and they receive technical and methodological assistance from the CDC as needed. The landline and cell phone numbers selected for the study are obtained through random sampling. This survey consists of three components: the core component, optional modules, and state added content-specific questions. Nationwide and state-specific rates are available for comparison. Due to the selection and weighting procedures, rates are generalizable for each state and the nation. Data including sample weighting information are publicly available from the CDC website and available for download and analysis including the BRFSS Data User Guide [9]. Data analysis occurred from 2019 through 2020.

Data analysis

Two dichotomous variables were combined to construct the binary dependent variable, self-report for cardiovascular disease (CVD) presence. This variable included the presence/absence of coronary heart disease (CHD) and/or myocardial infarction (MI). Participants were asked if a doctor, nurse, or other health professional had ever told them they have had coronary heart disease or myocardial infarction (MI). If the participant said yes to having either of these two conditions, they were considered to have CVD for analysis purposes. Independent variables were blocked in order to understand their respective contributions to the outcome of interest and included demographic variables (age, gender, race, and income), comorbid self-reported health conditions (cholesterol status, hypertension, diabetes, and BMI), as well as drinking, physical activity and smoking status. See Table 1 for the variables operational definitions.

Table 1. Operational definitions of variables.

Variables Definition
Age Categorized into four groups: 18–24 years old, 25–44 years old, 45–64 years old, and 65 years and older. For multiple logistic regression, age was categorized into 18–64 years old and 65 years and older.
Gender Categorized into males versus females
Race Categorized into five groups: White, non-Hispanic; Black, non-Hispanic; Hispanic; Other race, non-Hispanic; and Multiracial, non-Hispanic
Income Categorized into five groups: <$15,000, $15,000-$25,000, $25,000-$35,000, $35,000-$50,000, and > $50,000
Cholesterol Adults who have had cholesterol checked & told by a doctor, nurse/other healthcare professional it was high
Hypertension Adults who have been told they have high blood pressure, excluding pregnancy
Diabetes Adults who have been told they have diabetes, excluding pregnancy
BMI Calculated by the reported height and weight
Heavy drinkers Men having >14 drinks per week and women having >7 drinks per week
Physical activity Adults who met aerobic and strengthening guideline
Smoking status Categorized into four groups: current smoker every day, current smoker some days, former smoker, and never smoked
CHD or MI Have you ever been told you have CHD or MI, yes or no

Note: BMI; body mass index; CHD; coronary heart disease; MI; myocardial infarction.

Frequencies and weighted percentages for demographics were obtained overall, and the prevalence of select self-reported health variables by subgroup. Multiple logistic regression using the proc survey logistic procedure was utilized to model the association between the independent variables with CVD presence. Age-adjusted odds ratios and 95% confidence intervals were obtained. Age was a covariate in each model due to the strong association between age and CVD. Data were weighted in order to assure generalizability to the state of Nevada [9]. All analyses were conducted using SAS version 9.4.

Results

Demographics

The Nevada BRFSS dataset included a total of 5,493 and 3,764 subjects in 2011 and 2017, respectively. From both years, gender was evenly divided between females and males. Age was categorized into four groups: 18–24 years old, 25–44 years old, 45–64 years old, and 65 years and older. Over a third of the subjects in 2011 and 2017 were 25–44 years old (38.5% and 35.4%, respectively), white and non-Hispanic (58% and 53.5%, respectively) and with an income above $50,000 (37.5% and 44.8% respectively) (Table 2).

Table 2. BRFSS descriptive statistics for Nevada by year.

2011 2017
n (N = 5,493) Percent (%) n (N = 3,764) Percent (%)
GENDER
    Male 2241 50.6 1667 49.8
    Female 3252 49.4 2097 50.2
AGE
    18–24 290 11.7 228 11.3
    25–44 1292 38.5 821 35.4
    45–64 2238 33.6 1311 33.1
    65+ 1673 16.3 1404 20.2
RACE
    White, non-Hispanic 4233 58.0 2668 53.5
    Black, non-Hispanic 231 7.2 176 8.5
    Hispanic 505 23.8 576 24.8
    Other race, non-Hispanic 298 9.3 34 0.6
    Multiracial, non-Hispanic 142 1.7 118 1.9
INCOME
    < $15,000 466 11.2 266 9.0
    $15,000–24,999 835 22.3 537 20.6
    $25,000–34,999 533 12.6 322 11.3
    $35,000–49,999 759 16.4 463 14.4
    $50,000+ 2139 37.5 1523 44.8

Gender and age vs. the cardiovascular risk factors outcome

Gender and age group differences in reported cardiovascular risk factors for both years were examined. Between males versus females, there were significant differences with the following: current smoker, hypertension, BMI, and CVD in 2011, which is similar in 2017 except cholesterol became significant between the genders (Tables 2 and 3). Specifically, between males and females, females tend to have higher risk factors reported in both years. Among the different age categories, there were significant differences between all the cardiovascular risk factors except for heavy drinkers in 2011 and 2017. Specifically, middle-aged (45–64 years old) reported more cardiovascular risk factors compared to the other age groups for both years. BMI (overweight and obese) remained the most prevalent CVD risk factor. The second most common CVD risk factor was high cholesterol (37.3% and 33.1%, respectively), followed by hypertension (30.8% and 32.6%, respectively). Among the CVD risk factors, heavy drinkers were the least common representing approximately 6% of the population. The cardiovascular risk factor prevalence was similar for both years when stratified by gender and age. Specifically, the prevalence was higher in males versus females between ages 18–64, except for diabetes. In 2011, more males reported diabetes, while in 2017, more females had diabetes. Additionally, diabetes was more prevalent in adults older than 65 and older than the remaining population. Lastly, in 2017, those 65 years and older exhibited an increase in all CVD risk factors relative to 2011 (Table 3).

Table 3. 2011 & 2017 Nevada BRFSS gender and age outcome breakdown.

2011 Males Females p-value Age 18–24 Age 25–44 Age 45–64 Age 65 + p-value Overall*
Heavy Drinkers 170 (58.7%) 214 (41.3%) 0.055 23 (12.2%) 84 (39.8%) 171 (36.7%) 106 (11.3%) 0.107 384 (6.8%)
Current Smoker 456 (56.4%) 627 (43.6%) 0.008 47 (8.9%) 298 (45.2%) 518 (36.4%) 220 (9.5%) <0.001 1,083 (22.9%)
Cholesterol 796 (51.6%) 1,100 (48.4%) 0.264 9 — 199 (24.1%) 858 (44.9%) 830 (29.5%) <0.001 1,896 (37.3%)
Hypertension 892 (55.4%) 1,144 (44.6%) 0.007 23 — 187 (21.2%) 856 (43.0%) 970 (9.8%) <0.001 2,036 (30.8%)
BMI 1,536 (59.5%) 1,623 (40.5%) <0.001 105 (6.9%) 713 (40.0%) 1,390 (36.4%) 951 (16.7%) <0.001 3,159 (60.2%)
CVD 247 (59.1%) 246 (40.9%) 0.029 0 — 20 — 170 (40.2%) 303 (46.7%) <0.001 493 (7.0%)
Diabetes 267 (56.4%) 295 (43.6%) 0.135 3 — 33 (15.5%) 240 (47.0%) 286 (25.3%) <0.001 562 (10.3%)
2017 Males Females p-value Age 18–24 Age 25–44 Age 45–64 Age 65 + p-value Overall
Heavy Drinkers 113 (57.1%) 153 (42.9%) 0.117 18 (10.8%) 59 (44.2%) 107 (31.5%) 82 (13.5%) 0.062 266 (6.2%)
Current Smoker 271 (55.4%) 295 (44.6%) 0.070 16 (4.1%) 137 (37.7%) 253 (41.0%) 160 (17.2%) <0.001 566 (17.6%)
Cholesterol 597 (53.9%) 722 (46.1%) 0.010 6 — 127 (20.1%) 522 (45.5%) 664 (33.7%) <0.001 1,319 (33.1%)
Hypertension 692 (55.7%) 779 (44.3%) 0.001 11 — 127 (16.2%) 544 (44.9%) 789 (37.5%) <0.001 1,471 (32.6%)
BMI 1,156 (57.8%) 1,080 (42.2%) <0.001 105 (8.1%) 478 (35.6%) 848 (35.8%) 805 (20.5%) 0.002 2,236 (65.7%)
CVD 164 (61.0%) 1,491 (49.0%) 0.009 2 — 13 — 90 (40.6%) 215 (49.8%) <0.001 320 (6.8%)
Diabetes 215 (48.7%) 244 (51.3%) 0.719 1 — 25 (8.7%) 183 (49.0%) 250 (42.2%) <0.001 459 (10.4%)

Note.

*Overall non-grouped rate.—or N Excludes Unsure and No Response. BMI: Body Mass Index. CVD: Cardiovascular Disease.

Relationships of modifiable and non-modifiable cardiovascular risk factors

Multiple logistic regressions were performed to examine the association of different demographic and risk factors with CVD presence in Nevada by year. Adjusted odds ratios are reported. Compared to females, males were 1.64 times more likely to have reported CVD in 2011 [OR = 1.64 (1.15, 2.33)], which increased to 1.92 in 2017 [OR = 1.92 (1.29, 2.85)]. As expected, the age group 18–64 years old, when compared with 65 years and older, were 83% less likely to have reported CVD in 2011 [OR = 0.17 (0.12, 0.25)], which dropped to 73% in 2017 [OR = 0.27(0.18, 0.40)]. Among the different racial groups, Black non-Hispanics were 2.01 times more likely to have reported CVD in 2011 compared to White Non-Hispanic. Compared to Nevadans earning in the highest income level, those with an income level of less than $15,000 were 2.25 times [OR = 2.25 (1.34, 3.77)] and $15,000–25,000 were 2.06 times more likely [OR = 2.06 (1.19, 3.56)] to have reported CVD in 2011. Moreover, those in the income level of $25,000–35,000 were 2.30 times more likely to have reported CVD compared to those in the highest income level in 2017 [OR = 2.30 (1.19,4.42)] (S1 Table).

The study also examined the relationships of behavioral activities such as smoking, drinking alcohol, and physical activity. When adjusted for other risk factors, self-reported physical activity level was not significantly associated with CVD for either year. The relationship of heavy drinkers, when compared to non-heavy drinkers, changed from non-significant in 2011 to 77% less likely to have reported CVD [OR = 0.23 (0.08, 0.62)] in 2017. Compared to non-smokers, everyday smokers were 1.96 times more likely in 2011 [OR = 1.96 (1.16, 3.28)] and 3.62 times more likely in 2017 [OR = 3.62 (1.77, 7.44)] whereas former smokers were 2.12 times more likely in 2011 [OR = 2.12 (1.26, 3.57)] and 2.76 times more likely in 2017 [OR = 2.76 (1.76, 4.31)] to have reported CVD (Table 4).

Table 4. Behavioral risk factors associated with CVD by year.

Calculated Variable 2011 2017
OR 95% CI OR 95% CI
Heavy drinkers **
    No * 1.00 (1.00, 1.00) 1.00 (1.00, 1.00)
    Yes 0.68 (0.37, 1.28) 0.23 (0.08, 0.62)
Physical Activity ¥
    Met both guidelines 0.77 (0.46, 1.29) 0.63 (0.39, 1.04)
    Met aerobic guidelines only 0.57 (0.37, 1.29) 0.64 (0.40, 1.03)
    Met strengthening guidelines only 0.83 (0.31, 0.88) 0.64 (0.29, 1.41)
    Did not meet either guideline * 1.00 (1.00, 1.00) 1.00 (1.00, 1.00)
Smoker Status
    Current smoker–every day 1.96 (1.16, 3.28) 3.62 (1.77, 7.44)
    Current smoker–some days 1.41 (0.67, 3.00) 2.17 (0.96, 4.90)
    Former smoker 2.12 (1.26, 3.57) 2.76 (1.76, 4.31)
    Never smoked * 1.00 (1.00, 1.00) 1.00 (1.00, 1.00)
Age
    18–64 0.20 (0.13, 0.31) 0.24 (0.16, 0.35)
    65 or older * 1.00 (1.00, 1.00) 1.00 (1.00, 1.00)

*Reference group.

**Men having >14 drinks per week and women having >7 drinks per week.

¥: Adults who met aerobic and strengthening guidelines.

The relationships between comorbid illnesses and CVD in Nevada were also examined. Individuals with high cholesterol status were 2.67 times more likely to have reported CVD compared to those with normal levels [OR = 2.67 (1.75, 4.07)] in 2011. However, this relationship was attenuated and lost significance in 2017. In 2011 individuals with hypertension were 3.74 times more likely to have reported CVD compared to those who did not have hypertension [OR = 3.74 (2.42, 5.77)]. This relationship increased its magnitude of risk to 6.18 times more likely in 2017 [OR = 6.18 (3.70, 10.33)]. The increase in the relationship of hypertension with CVD other factors in the model in 2017. In 2011 individuals with diabetes were 2.90 times more likely to have reported CHD or MI [OR = 2.90 (1.81, 4.65)] compared to those without the condition. The strength of this relationship decreased to 1.89 more likely in 2017 [OR = 1.89 (1.18, 3.05)]. Compared to average weight, those of elevated BMI levels did not demonstrate a significant increase of CVD; however, underweight individuals were 3.30 times more likely to have reported CVD [OR = 3.30 (1.29, 8.44)] in 2011. While in 2017 underweight individuals were 89% less likely to have reported CVD compared to those of average weight [OR = 0.11 (0.02, 0.55)]. Notably, hypertension was the leading cardiovascular risk factor when compared to cholesterol, diabetes, BMI, and age (Table 5).

Table 5. Comorbid risk factors associated with CVD by year.

Calculated Variable 2011 2017
OR 95% CI OR 95% CI
Cholesterol Status a
    No, checked but not been told high * 1.00 (1.00, 1.00) 1.00 (1.00, 1.00)
    Yes, checked and been told high 2.67 (1.75, 4.07) 1.46 (0.94, 2.27)
Hypertension Status b
    No * 1.00 (1.00, 1.00) 1.00 (1.00, 1.00)
    Yes 3.74 (2.42, 5.77) 6.18 (3.70, 10.33)
Diabetes Status c
    No * 1.00 (1.00, 1.00) 1.00 (1.00, 1.00)
    Yes 2.90 (1.81, 4.65) 1.89 (1.18, 3.05)
Age
    18–64 0.39 (0.26, 0.58) 0.43 (0.28, 0.67)
    65 or older * 1.00 (1.00, 1.00) 1.00 (1.00, 1.00)
Adult BMI
    Underweight 3.30 (1.29–8.44) 0.11 (0.02, 0.55)
    Normal weight * 1.00 (1.00, 1.00) 1.00 (1.00, 1.00)
    Overweight 0.90 (0.59, 1.36) 1.36 (0.85, 2.18)
    Obese 0.75 (0.42, 1.34) 1.23 (0.70, 2.17)

*Reference group.

Discussion

The main aim of the study was to find the relationship between different cardiovascular risk factors and CVD among adult Nevadans in 2011 and 2017. Thus, the study provides an overview of how cardiovascular risk factors among this population has changed in 6 years. The study found some anticipated results as well as other interesting relationships and trends. As expected, males had higher odds of reporting CVD than females, and this increased between years. Interestingly, the literature also demonstrated that adult males had a higher risk of CVD compared to females; however, the gender gap closes as females gets older [10, 11]. Similarly, the younger age group had less likelihood of reporting CVD in 2011, compared to the older age group. Although the younger age group still had less likelihood of reporting CVD in 2017, this percentage was less compared to 2011 indicating increased prevalence among the 18–64 years age group. Andersson and Vasan’s review indicated that CVD rates are increasing among younger adults, which could be due to high prevalence of obesity and lack of exercise and nutritious food [12]. As this population grow older, the healthcare industry needs to be better prepared and educated to care for them. Among racial groups, as expected, Black Non-Hispanics were more likely to have reported CVD compared to White Non-Hispanics; however, there were no significant racial differences in reported CVD in 2017. Because data collected were cross-sectional in nature, the population was different at these two-time points. However, the random digit dialing methodology and weighting protocol for this survey assure that the findings are representative of the state for any given year. With more focus on reducing health disparity, this finding is a positive and expected outcome. However, it will be interesting to see if this trend continues in the future and if any preventive measures exist to reduce the burden of CVD in Nevada. There has been documented evidence in the literature supporting the use of preventive measures to reduce CVD, which the AHA reports summarized [1, 13]. In 2011, lower income was associated with a higher odds of reporting CVD compared to a higher income level. However, in 2017, Nevadans reporting less than $15,000 annual income continued to have higher likelihood of reporting CVD with a slight increase in odds relative to 2011 and income group of $25–35,000 became significant in terms of increased risk compared to $50,000 or higher income level group. The increased odds in the lowest income level attenuated and were no longer significant in 2017. Overall, Nevadans with lower earnings had higher odds of self-reported CVD. This is consistent with the literature as lower socioeconomic status is related to lack of access to quality health care, which in turn increases the likelihood of elevated CVD prevalence and higher hospital readmission rates [14, 15].

Along with the relationship of different demographic factors, the study also looked at modifiable cardiovascular risk factors (behavioral and health conditions) in Nevada. In order to reduce bias, age was adjusted for in each model due to the strong and linear relationship between age and having a heart event. Among different behavioral factors, it is interesting to note that physical activity was not significantly associated with CVD in both years. This could be explained by the limitations of self-report data instead of objective measurements. This is in contrast to current literature, which indicates that any kind of physical activity is beneficial to cardiovascular health [16]. The non-significant relationship between heavy drinking and CVD was significant in 2017. In 2017, heavy drinkers were less likely to have reported CVD when compared to non-heavy drinkers. In this study, alcohol consumption demonstrated a slight protective effect on cardiovascular health. Research has indicated that alcohol shows a U-shaped relationship with CVD, indicating that low or moderate drinking may be beneficial for cardiovascular health concerning abstinence or abusive drinking [17]. Protective characteristics of moderate alcohol drinking are associated with its blood-thinning properties, reduced inflammatory response and increased high-density lipoprotein [18]. Compared to non-smokers, regular smokers, and former smokers were at greater risk. This risk was higher for everyday smokers and the odds increased in 2017 for both of these groups. These data did not provide further explanation on who the former smokers were and when they had the heart event; therefore, temporality could not be established. Former smokers may have experienced the heart event prior to quitting. Smoking continues to remain one of the modifiable risk factors of CVD although there has been significant improvement in preventive measures to reduce CVD and smoking cessation programs [19]. Although smoking use in Nevada continues to decline, there is still initiatives to prevent secondhand exposure as evident by continuous funding from CDC to prevent and control smoking [20].

Among different health conditions that were examined, hypertension had the most substantial relationship to self-reported CVD. This relationship increased from 3-fold in 2011 to over 6-fold risk in 2017, causing the other comorbidities to attenuate or become insignificant. Nevadans with diabetes were at greater risk for both years. Nevadans with elevated cholesterol status had higher odds of reporting CVD in 2011, yet this relationship was not significant in 2017. This could be due to the dominating relationship of hypertension with the outcome. This is in support of the literature as hypertension is one of the significant documented cardiovascular risk factors in the literature, along with obesity [21, 22]. It is important to note that hypertension rates will increase partially due to the new blood pressure classification guidelines implemented for tighter blood pressure control [4]. There has been lot of research indicating that obesity is one of the modifiable risk factors of CVD [1]. However, in our study obesity was not a significant predictor of CVD. There have been studies to support that the risk of CVD associated with obesity is mainly due to comorbid conditions [23, 24]. This is reflected in our findings where comorbid conditions such hypertension and diabetes are better predictors of CVD. One of the interesting findings of this study is that compared to normal weight, individuals who were underweight had reported higher odds of CVD in 2011 and lower risk in 2017. Further analyses are needed to understand this interesting association. However, fewer research in underweight and CVD has shown contrasting findings. Research indicating increased CVD risk with underweight have associated this risk with lack of proper nutritional status and those with lower CVD risk have associated underweight with lower cholesterol and without comorbid conditions such as diabetes and hypertension [25, 26].

Limitations

This study is not without limitations. First, this study’s assessment and variables relied on self-report; therefore, misclassification is a possibility due to recall bias. We also lack objective measurements in physical activity, as well as clinical markers such as fasting lipid panels, glucose, and blood pressure readings taken by a trained professional. Another limitation is the lifetime prevalence of CVD, it is quite possible that participants have made lifestyle changes post-heart events. This would explain some unexpected findings in the study, such as the insignificant association between physical activity and cardiovascular condition. Thirdly, despite this study being a population-based research design, it is cross-sectional; therefore, the sample changed over time. However, using the BRFSS dataset provided a large sample size of over 9000 participants with a better representation of the state. Generalizability can be made because of the BRFSS weighting and inclusion of random individuals that eliminate selection biases.

Implications and conclusions

To reduce CVD, public health and healthcare providers need to target preventable cardiovascular risk factors and develop recommendations and strategies. Currently, locally and nationally, strategies and efforts are in place to reduce the CVD burden. This includes the AHA recommendations of the Life’s Simple 7 (stop smoking, eat better, get active, lose weight, manage blood pressure, control cholesterol, and reduce blood sugar) and Healthy People 2020 goals and objectives to increase overall cardiovascular health in the United States population which have achieved little success. Specifically, this study identified hypertension as the leading cardiovascular risk factor, which warrants a closer examination of our current practice in clinical, research, and policy to reduce prevalence statewide and nationally. The long-term benefit of addressing modifiable cardiovascular risk factors such as hypertension before heart health declines may be impactful, including improved quality of life as well as decreases in the economic burden to the health care system. When it comes to preventable risk factors, primary prevention should be a priority locally, nationally, and globally.

Supporting information

S1 Table. Sociodemographic factors associated with CVD by year.

(DOCX)

Data Availability

The data underlying the results presented in the study are available from the Behavioral Risk Factor Surveillance System website (https://www.cdc.gov/brfss/data_documentation/index.htm).

Funding Statement

The authors received no specific funding for this work.

References

  • 1.Benjamin EJ, Muntner P, Bittencourt MS. Heart disease and stroke statistics-2019 update: A report from the american heart association. Circulation. 2019;139(10):e56–e528. 10.1161/CIR.0000000000000659 [DOI] [PubMed] [Google Scholar]
  • 2.Tran DT, Kupzyk KA, Zimmerman LM. Using cluster analysis to identify subgroups of college students at increased risk for cardiovascular disease. J Nurs Meas. 2018;26(3):470–482. 10.1891/1061-3749.26.3.470 [DOI] [PubMed] [Google Scholar]
  • 3.CDC. Know your risk for heart disease. 2019. Available from: https://www.cdc.gov/heartdisease/risk_factors.htm [Google Scholar]
  • 4.Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the american college of cardiology/american heart association task force on clinical practice guidelines. Circulation. 2017;00:e000. [DOI] [PubMed] [Google Scholar]
  • 5.National Heart, Lung, and Blood Institute. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. NIH publication. 2004(04–5230). [PubMed] [Google Scholar]
  • 6.He FJ, MacGregor GA. Effect of modest salt reduction on blood pressure: A meta-analysis of randomized trials. implications for public health. J Hum Hypertens. 2002;16(11):761 10.1038/sj.jhh.1001459 [DOI] [PubMed] [Google Scholar]
  • 7.Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA: A Cancer Journal for Clinicians. 2017;67(1):7–30. https://onlinelibrary.wiley.com/doi/abs/10.3322/caac.21387. [DOI] [PubMed] [Google Scholar]
  • 8.Teramoto M, Moonie S, Cross CL, Chino M, Alpert PT. Association of leisure-time physical activity to cardiovascular disease prevalence in relation to smoking among adult nevadans. PloS one. 2015;10(5). 10.1371/journal.pone.0128424 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.CDC. Behavioral risk factor surveillance system. 2019. Available from: https://www.cdc.gov/brfss/ [Google Scholar]
  • 10.Dib JG, Alameddine Y, Geitany R, Afiouni F. National cholesterol education panel III performance in preventing myocardial infarction in young adults. Ann Saudi Med. 2008;28(1):22–27. 10.5144/0256-4947.2008.22 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Loria CM, Liu K, Lewis CE, et al. Early adult risk factor levels and subsequent coronary artery calcification: The CARDIA study. J Am Coll Cardiol. 2007;49(20):2013–2020. 10.1016/j.jacc.2007.03.009 [DOI] [PubMed] [Google Scholar]
  • 12.Andersson Charlotte, and Vasan Ramachandran S. "Epidemiology of cardiovascular disease in young individuals." Nature Reviews Cardiology. 2018;15(4):230 10.1038/nrcardio.2017.154 [DOI] [PubMed] [Google Scholar]
  • 13.Goff DC Jr, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: A report of the american college of cardiology/american heart association task force on practice guidelines. Circulation. 2014;129(25 Suppl 2):49. [DOI] [PubMed] [Google Scholar]
  • 14.Parikh PB, Yang J, Leigh S, et al. The impact of financial barriers on access to care, quality of care and vascular morbidity among patients with diabetes and coronary heart disease. Journal of general internal medicine. 2014;29(1):76–81. 10.1007/s11606-013-2635-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Schultz WM, Kelli HM, Lisko JC, et al. Socioeconomic status and cardiovascular outcomes: Challenges and interventions. Circulation. 2018;137(20):2166–2178. 10.1161/CIRCULATIONAHA.117.029652 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Lavie C. J., Ozemek C., Carbone S., Katzmarzyk P. T., & Blair S. N. Sedentary behavior, exercise, and cardiovascular health. Circulation research. 2019;124(5):799–815. 10.1161/CIRCRESAHA.118.312669 [DOI] [PubMed] [Google Scholar]
  • 17.Chiva-Blanch G, Badimon L. Benefits and risks of moderate alcohol consumption on cardiovascular disease: Current findings and controversies. Nutrients. 2020;12(1):108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Piano MR. Alcohol’s effects on the cardiovascular system. Alcohol research: current reviews. 2017;38(2):219 [PMC free article] [PubMed] [Google Scholar]
  • 19.Burke G. M., Genuardi M., Shappell H., D’Agostino Sr, R. B., & Magnani J. W. Temporal associations between smoking and cardiovascular disease, 1971 to 2006 (from the Framingham Heart Study). The American journal of cardiology. 2017;120(10):1787–1791. 10.1016/j.amjcard.2017.07.087 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.CDC. Smoking & Tobacco Use–Extinguishing the Tobacco Epidemic in Nevada. 2020. Available from: https://www.cdc.gov/tobacco/about/osh/state-fact-sheets/nevada/index.html [Google Scholar]
  • 21.James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the eighth joint national committee (JNC 8). JAMA. 2014;311(5):507–520. 10.1001/jama.2013.284427 [DOI] [PubMed] [Google Scholar]
  • 22.Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the european society of hypertension (ESH) and of the european society of cardiology (ESC). Blood Press. 2013;22(4):193–278. 10.3109/08037051.2013.812549 [DOI] [PubMed] [Google Scholar]
  • 23.Lu Y, Hajifathalian K, Ezzati M, et al. Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration (BMI Mediated Effects). Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants. Lancet.2014;383:970–83. 10.1016/S0140-6736(13)61836-X [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Wormser D, Kaptoge S, Di Angelantonio E, et al. Emerging Risk Factors Collaboration. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet.2011;377:1085–95 10.1016/S0140-6736(11)60105-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Park D, Lee JH, Han S. Underweight: another risk factor for cardiovascular disease?: a cross-sectional 2013 Behavioral Risk Factor Surveillance System (BRFSS) study of 491,773 individuals in the USA. Medicine.2017;96(48). 10.1097/MD.0000000000008769 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Loprinzi PD, Crespo CJ, Andersen RE, Smit E. Association of body mass index with cardiovascular disease biomarkers. American Journal of Preventive Medicine.201548(3):338–44. 10.1016/j.amepre.2014.08.019 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Sabine Rohrmann

22 Dec 2020

PONE-D-20-26195

Behavioral Risk Factors Associated with Cardiovascular Disease among Adult Nevadans

PLOS ONE

Dear Dr. Tran,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Feb 05 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Sabine Rohrmann

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

3. Thank you for stating the following financial disclosure:

'NO - The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Acknowledgements: The publication fees for this article were supported by the UNLV University Libraries Open Article Fund (if accepted for publication).'

At this time, please address the following queries:

  1. Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution.

  2. State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

  3. If any authors received a salary from any of your funders, please state which authors and which funders.

  4. If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The purpose of this cross-sectional study is to examine the association between self-reported risk factors (heavy drinking, smoking, high cholesterol, hypertension, overweight/obesity, and diabetes) and CVD presence among adult Nevadans. However, some issues need to be clarified or revised:

1) Some of the self-reported risk factors (cholesterol, hypertension, diabetes) are not behavioral risk factors. The title of this manuscript is improper.

2) Several variables such as hypertension, diabetes, high cholesterol, obesity (BMI) and smoking are not clearly defined. Please give details.

3) The description of methodology and data analysis is not rigorous enough. For example, the raking weighting methodology should be more specific including the weighted variables. The BRFSS Data User Guide of CDC should also be referenced.

4) Please show the data in line122-134 in a table format.

5) 95% confidence intervals (CIs) and the missing number of each subgroup are necessary in Table1, 2 and 3.

6) In order to avoid ambiguity, weighted percentages should also be illustrated below each table.

7) Some data in Table 2 and 3 do not have percentages. (e.g., 9--,23--,20--, etc) Please illustrate the meaning below each table. Meanwhile, please add the abbreviations.

8) There are several data errors in these tables. Please recheck them carefully. (e.g., the percentage of female current smoker in Table 3 is15.8%; number of male CVD in Table 3 is 164, etc)

9) Nineteen references may be insufficient. Further discussion is needed instead of retelling the results.

10) Please do not use semicolons in sentences!

11) Several minor errors should be revised as follow: “mg/dL” should be “mg/d” in line 41; some brackets are italic; “0.23 0.08, 0.62)” should be “0.23 (0.08, 0.62)” in line 139.

Reviewer #2: 1. The study examined the association between risk factors and CVD presence among adult Nevadans between 2011 and 2017, but it is less objective since the study relied on the self-reporting.

2. Multiple logistic regressions were performed to examine the association of different demographic and risk factors with CVD presence in Nevada by year. Please add a table showing all the result, so difference would be obvious between 2011 and 2017.

3.Age was categorized into four groups: 18-24 years old, 25-44 years old, 45-64 years old, and 65 years and

100 older. Could you please give a reason of age categories in this study.

4.BMI (overweight and obese) remained the most prevalent CVD risk factor. However, compared to normal weight, there was huge difference of underweight individuals on reporting CVD(Table 5). Please provide some further discussion on it.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Decision Letter 1

Sabine Rohrmann

2 Feb 2021

Risk Factors Associated with Cardiovascular Disease among Adult Nevadans

PONE-D-20-26195R1

Dear Dr. Tran,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Sabine Rohrmann

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Sabine Rohrmann

4 Feb 2021

PONE-D-20-26195R1

Risk Factors Associated with Cardiovascular Disease among Adult Nevadans

Dear Dr. Tran:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Sabine Rohrmann

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Sociodemographic factors associated with CVD by year.

    (DOCX)

    Attachment

    Submitted filename: Response to Reviewers Table 1.28.21.docx

    Data Availability Statement

    The data underlying the results presented in the study are available from the Behavioral Risk Factor Surveillance System website (https://www.cdc.gov/brfss/data_documentation/index.htm).


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES